Auletta Sveva, Varani Michela, Horvat Rika, Galli Filippo, Signore Alberto, Hess Søren
Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
Department of Radiology and Nuclear Medicine, Hospital of Southwest Jutland, 6700 Esbjerg, Denmark.
J Clin Med. 2019 Feb 6;8(2):197. doi: 10.3390/jcm8020197.
Bacterial infections are still one of the main factors associated with mortality worldwide. Many radiopharmaceuticals were developed for bacterial imaging, both with single photon emission computed tomography (SPECT) and positron emission tomography (PET) isotopes. This review focuses on PET radiopharmaceuticals, performing a systematic literature review of published studies between 2005 and 2018.
A systematic review of published studies between 2005 and 2018 was performed. A team of reviewers independently screened for eligible studies. Because of differences between studies, we pooled the data where possible, otherwise, we described separately. Quality of evidence was assessed by (QUADAS) approach.
Eligible papers included 35 published studies. Because of the heterogeneity of animal models and bacterial strains, we classified studies in relation to the type of bacterium: Gram-positive, Gram-negative, Gram-positive and negative, others.
Results highlighted the availability of many promising PET radiopharmaceuticals for bacterial imaging, despite some bias related to animal selection and index test, but few have been translated to human subjects. Results showed a lack of standardized infection models and experimental settings.
细菌感染仍是全球范围内与死亡率相关的主要因素之一。许多放射性药物被开发用于细菌成像,包括单光子发射计算机断层扫描(SPECT)和正电子发射断层扫描(PET)同位素。本综述聚焦于PET放射性药物,对2005年至2018年间发表的研究进行系统的文献综述。
对2005年至2018年间发表的研究进行系统综述。一组评审员独立筛选符合条件的研究。由于研究之间存在差异,我们尽可能合并数据,否则分别进行描述。采用(QUADAS)方法评估证据质量。
符合条件的论文包括35项已发表的研究。由于动物模型和细菌菌株的异质性,我们根据细菌类型对研究进行分类:革兰氏阳性菌、革兰氏阴性菌、革兰氏阳性菌和阴性菌、其他。
结果强调了许多有前景的用于细菌成像的PET放射性药物的可用性,尽管在动物选择和指标测试方面存在一些偏差,但很少有药物已转化应用于人体受试者。结果显示缺乏标准化的感染模型和实验设置。